Abstract
Tuberculosis remains a global health crisis in part due to underdiagnosis. Technological innovations are needed to improve diagnostic test accuracy and reduce the reliance on expensive laboratory infrastructure. However, there are significant economic challenges impeding the development and implementation of new diagnostics. The aim of this piece is to examine the current state of TB diagnostics, outline the unmet needs for new tests, and detail the economic challenges associated with development of new tests from the perspective of developers, policy makers and implementers.
Original language | English (US) |
---|---|
Pages (from-to) | 499-510 |
Number of pages | 12 |
Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
Volume | 14 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2014 |
Keywords
- Diagnostic development
- Diagnostics
- Economic evaluation
- Tuberculosis
- Tuberculosis control policy
ASJC Scopus subject areas
- Health Policy
- Pharmacology (medical)